University of Alabama Birmingham
Endothelial N-Glycan Hypoglycosylation Enhances Cd16+ Monocyte Adhesion: A Role For Alpha-Mannosidases
Abstract
dc:description.abstractMonocyte extravasation through the endothelial layer is a hallmark of atherosclerotic plaque development and is mediated by heavily glycosylated surface adhesion molecules, such as intercellular adhesion molecule-1 (ICAM-1). Human monocytes have been classified into three distinct groups: classical (anti-inflammatory; CD14+/CD16-), nonclassical (patrolling; CD14+/CD16++), and intermediate (pro-inflammatory; CD14++/CD16+). The CD16+ nonclassical / intermediate monocytes have been implicated in atherosclerosis progression and their levels positively associate with adverse cardiac events. However, there is a relative lack of understanding as to whether there are distinct mechanisms that regulate CD16+ vs. CD16- monocyte adhesion to the inflamed endothelium. Our previous data identified a high-mannose (HM) glycoform of ICAM-1 present during inflammation, but the function of different endothelial N-glycoforms is not yet known. Here, we test the hypothesis that distinct ICAM-1 N-glycoforms mediate recruitment of different monocyte subsets and specifically that endothelial HM-ICAM-1 promotes adhesion of CD16+ monocytes. We measured monocyte rolling and adhesion to i) TNFalpha-activated HUVEC, in which N-glycosylation was modulated by inhibiting alpha- mannosidase activity or by lectin-based blocking or ii) Cos-1 cells expressing HM- or complex ICAM-1. Expression of HM-ICAM-1 selectively enhanced CD16+ monocyte adhesion under flow with no effect on CD16- monocytes noted. This effect was dependent upon both HM epitopes and ICAM-1; adhesion was abrogated by blocking either. iv Further, using the proximity ligation assay (PLA) we show that HM-ICAM-1 is present in human and mouse atherosclerosis, increasing with disease severity and positively correlating with CD68 macrophage staining. Finally, we addressed the mechanism behind the formation of HM-ICAM-1 during inflammation by studying endothelial alpha-mannosidases, a class of enzymes responsible for early N-glycan processing. We show that TNFalpha decreases class I alpha-mannosidase activity in a time-dependent manner, resulting in formation of HM-ICAM-1 on the cell surface. We also show that this decrease in activity is independent of NF-kappaB, suggesting a parallel mechanism of N-glycan regulation distinct from up-regulation of adhesion molecule protein expression. Together, these data highlight a high-mannose ICAM-1 present in human and mouse atherosclerotic lesions as a key mediator of CD16+ monocyte recruitment to the endothelium, and identify alpha-mannosidases as a potential therapeutic target in atherosclerosis.
Degree
thesis:*- Level thesis:degree_level
- Dissertation
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- McDonald, Kellie Regal
- Contributors dc:contributor
-
- Rakesh P Patel
- Scott Ballinger
- Jarrod Barnes
- Susan Bellis
- Silvio Litovsky
- Jan Novak
Subjects
dc:subject × 7Identifiers
dc:identifier.*- Repository record dc:identifier
- https://digitalcommons.library.uab.edu/etd-collection/2431